Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.970
-0.050 (-2.48%)
Dec 4, 2025, 4:00 PM EST - Market closed
Celularity Market Cap
Celularity has a market cap or net worth of $55.81 million as of December 5, 2025. Its market cap has decreased by -8.36% in one year.
Market Cap
55.81M
Enterprise Value
122.53M
1-Year Change
-8.36%
Ranking
Category
Stock Price
$1.97
Market Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $55.81M, a decrease of -84.15%. That is a compound annual growth rate of -25.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 55.89M | 19.51% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | 395.31M | 10.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.98B |
| Johnson & Johnson | 495.66B |
| AbbVie | 407.28B |
| UnitedHealth Group | 307.12B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 255.13B |
| Thermo Fisher Scientific | 219.23B |